Valerie Montgomery Rice, MD, FACOG, President and CEO of Morehouse School of Medicine, Appointed Special Advisor to GeoVax
First Woman President and CEO of MSM and Internationally Recognized Health Equity Advocate Joins in GeoVax Special Advisory Role
ATLANTA, GA, Dec. 20, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — GeoVax Labs, Inc. (Nasdaq:GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, announced today the appointment of Valerie Montgomery Rice, MD, FACOG, Morehouse School of Medicine President and CEO, as Special Advisor to the Chairman/CEO and Board of Directors of GeoVax.
Related news for (GOVX)
- Breaking News: MoBot’s Latest Update as of 07/08/25 03:00 PM
- Don’t Miss Out: MoBot’s Latest Stock Updates 06/18/25 04:00 AM
- MoBot alert highlights: NASDAQ: TMC, NASDAQ: URGN, NASDAQ: NCPL, NASDAQ: EYEN, NASDAQ: GOVX (06/16/25 03:00 PM)
- MoBot’s Stock Market Highlights – 06/16/25 11:00 AM
- GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster